Navigation Links
USC researchers discover new molecular subtype of brain cancer
Date:4/15/2010

Los Angeles, Calif., April 15, 2010A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments.

The research by The Cancer Genome Atlas (TCGA), published online today in the journal Cancer Cell, used epigenomics to determine that tumor DNA methylation profiles were distinctly different in about 10 percent of patients with glioblastoma multiforme (GBM).

"Most GBM patients survive fewer than 15 months, and fewer than 10 percent live more than five years," said Peter W. Laird of the USC Epigenome Center, who led the TCGA team in collaboration with Dr. Kenneth Aldape at M.D. Anderson Cancer Center, Dr. Stephen B. Baylin at Johns Hopkins School of Medicine and many other TCGA consortium members. "With this research, we have identified a subset of patients with a distinct type of GBM that have substantially better clinical outcomes, with a median survival time of more than three years from the time of diagnosis."

Epigenomics is the study of how DNA is packaged and marked to control which genes can be used in a particular type of cell or tissue. The distribution of one of these marks along the DNA, called DNA methylation, is often abnormal in cancer, contributing to the disease process. The characteristic epigenetic profile discovered by the TCGA team is called G-CIMP (Glioma CpG Island Methylator Phenotype) and was found to occur in much younger patients. G-CIMP tumors have other distinct alterations in their genomic landscape, revealing an interesting association with an acquired mutation in the IDH1 gene.

"Such findings are critical to the detection and treatment of brain cancer based on the genetic or epigenetic profile of each patient's disease," said National Institutes of Health (NIH) Director Francis Collins, M.D., Ph.D. "The depth and breadth of expertise in The Cancer Genome Atlas research network, combined with ever-improving genomic technologies, is generating remarkably detailed insights into cancer."


'/>"/>

Contact: Leslie Ridgeway
leslie.ridgeway@usc.edu
323-442-2823
University of Southern California
Source:Eurekalert

Related medicine news :

1. Plant pathogen genetically tailors attacks to each part of host, say Stanford researchers
2. Researchers find compound effective in destroying antibiotic-resistant biofilms
3. Boston researchers lead $15 million federal research grant to support advancement of health IT
4. Researchers discover new approach for identifying smokers at highest risk for developing lung cancer
5. Researchers aim for consensus on measuring the impact of visual impairment
6. Researchers Boost Post-Heart Attack Survival in Mice
7. Researchers quantify benefits of minimally invasive removal of hard-to-reach tumors
8. Researchers design self-test for memory disorders
9. Researchers identify potential new target for treating hepatitis C
10. Researchers Identify 2 Genes Linked to Fatty Liver Disease
11. NIA researchers find gene to explain mouse embryonic stem cell immortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... of a higher risk of serious health problems, such as cardiovascular illness, according ... Peiman Soleymani of Beverly Hills Periodontics & Dental Implant Center notes that the ...
(Date:12/6/2016)... , ... December 06, 2016 , ... An inventor, from ... utilize a sling, so she invented the patent-pending SLING-VEST. , The SLING-VEST provides an ... offers an improved alternative to traditional slings. As a result, it helps to reduce ...
(Date:12/6/2016)... ... December 06, 2016 , ... Mount Sinai Health System today ... of Neurosurgery, where clinicians can confer and order 3D models for their cases. ... basis with quick turnaround times. This resource will be the first of its ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Touchpoint Solution’s new neuroscience wearable, ... Almost 200 backers pledged more than $25,000 on Kickstarter to bring ... Dr. Amy Serin, an Arizona Neuropsychologist and inventor, says she feels like she stumbled ...
(Date:12/6/2016)... ... December 06, 2016 , ... After 30 years ... Susan Glasgow has announced her retirement from HASA at the end ... more than 4,000 individuals and families with hearing and speech services. She has ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
(Date:12/6/2016)... , Dec. 6, 2016 A new study ... of 340B (AIR 340B) projects the 340B Drug Pricing Program ... by which time it is expected to exceed $23 billion ... would see 340B purchases surpass current Medicare Part B drug ... The new study – based on analysis of data on ...
(Date:12/6/2016)... Tenn , Dec. 6, 2016  In response ... dependent on opioids every 25 minutes, a respected group ... company that will provide a holistic suite of services ... Based on his own experience trying to ... social entrepreneur Justin Lanning launched 180 ...
Breaking Medicine Technology: